NSC |
Compound |
Enrichment |
Correlation |
NSC 357704 |
Cyanomorpholinodoxorubicin |
0.00104257542638397 |
-0.080502938 |
NSC 693986 |
Pyrimidine-2,4(1H,3H)-dione, 1-[1,2-bis(ethoxycarbonyl)ethenyl]-5-methyl-3-propynyl-, (E)-, |
0.00104257542638397 |
0.46729573 |
NSC 706739 |
Benzo[c]pyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione, 2-(dimethylamino)-5-ethyl- 3b,4,5,6,7,7a,12,12b-octahydro-9-methyl- |
0.00104257542638397 |
0.046642521 |
NSC 726311 |
Null |
0.00104257542638397 |
-0.070811192 |
NSC 684902 |
Null |
0.00134664791567076 |
-0.097802574 |
NSC 693773 |
Null |
0.00134664791567076 |
-0.16467974 |
NSC 163949 |
3,6-Diamino-10-methylacridinium chloride hydrochloride |
0.00162803849483079 |
-0.17394056 |
NSC 606699 |
Rapamycin prodrug, Mono-(28)-N,N-diethylpropionate-, hydrochloride salt |
0.00162803849483079 |
-0.33362857 |
NSC 658837 |
Null |
0.00162803849483079 |
-0.19204342 |
NSC 689626 |
Null |
0.00162803849483079 |
0.12654177 |